XML 70 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Loss - USD ($)
shares in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net product revenue $ 27,963,000 $ 0 $ 0
Cost of products sold 846,000 0 0
Gross profit 27,117,000 0 0
Operating expenses:      
Research and development expenses 13,261,000 20,700,000 17,104,000
Selling, general and administrative expenses 151,705,000 74,516,000 68,495,000
Restructuring expense (income) 0 3,345,000 (53,000)
Total operating expenses 164,966,000 98,561,000 85,546,000
Operating loss (137,849,000) (98,561,000) (85,546,000)
Investment and other income (expense), net 87,000 (536,000) 2,343,000
Interest expense (9,886,000) (12,342,000) (9,942,000)
Loss on extinguishment of debt (13,129,000) 0 0
Loss before income taxes (160,777,000) (111,439,000) (93,145,000)
Income tax (benefit) provision (501,000) 26,025,000 (15,816,000)
Net loss $ (160,276,000) $ (137,464,000) $ (77,329,000)
Net loss per share - basic (in usd per share) $ (2.00) $ (2.29) $ (1.32)
Net loss per share - diluted (in usd per share) $ (2.00) $ (2.29) $ (1.32)
Weighted average number of shares outstanding - basic (in shares) 80,174 60,094 58,535
Weighted average number of shares outstanding - diluted (in shares) 80,174 60,094 58,535